Advanced search
1 file | 792.88 KB

Magnetic resonance imaging in diagnosis, staging and radiotherapy planning for prostate cancer

(2010) ACTA CLINICA BELGICA. 65(6). p.371-376
Author
Organization
Abstract
T2-weighted magnetic resonance imaging (MRI), preferably using an endorectal coil, is able to clearly depict the normal prostatic anatomy and to identify prostate cancer with fair diagnostic accuracy. The latter can be further increased by using functional techniques such as spectroscopy (assessment of prostatic metabolism), dynamic contrast-enhanced MRI (assessment of angiogenesis) and diffusion-weighted imaging (assessment of cellular density). T2-weighted MRI is an important tool for local staging of prostate cancer in patients clinically staged as cT1 or cT2, because of its high specificity for macroscopic capsular extension or seminal vesicle invasion. Compared to CT-imaging, MRI depicts the internal prostatic anatomy, prostatic margins and the extent of prostatic tumors much more clearly. This benefit can be exploited to improve the accuracy of target delineations in radiotherapy planning.
Keywords
Magnetic Resonance Imaging, Magnetic Resonance Spectroscopy, Prostate Cancer.

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 792.88 KB

Citation

Please use this url to cite or link to this publication:

Chicago
Villeirs, Geert, Pieter De Visschere, VALERIE FONTEYNE, Nicolaas Lumen, and Gert De Meerleer. 2010. “Magnetic Resonance Imaging in Diagnosis, Staging and Radiotherapy Planning for Prostate Cancer.” Acta Clinica Belgica 65 (6): 371–376.
APA
Villeirs, G., De Visschere, P., FONTEYNE, V., Lumen, N., & De Meerleer, G. (2010). Magnetic resonance imaging in diagnosis, staging and radiotherapy planning for prostate cancer. ACTA CLINICA BELGICA, 65(6), 371–376.
Vancouver
1.
Villeirs G, De Visschere P, FONTEYNE V, Lumen N, De Meerleer G. Magnetic resonance imaging in diagnosis, staging and radiotherapy planning for prostate cancer. ACTA CLINICA BELGICA. 2010;65(6):371–6.
MLA
Villeirs, Geert, Pieter De Visschere, VALERIE FONTEYNE, et al. “Magnetic Resonance Imaging in Diagnosis, Staging and Radiotherapy Planning for Prostate Cancer.” ACTA CLINICA BELGICA 65.6 (2010): 371–376. Print.
@article{1109619,
  abstract     = {T2-weighted magnetic resonance imaging (MRI), preferably using an endorectal coil, is able to clearly depict the normal prostatic anatomy and to identify prostate cancer with fair diagnostic accuracy. The latter can be further increased by using functional techniques such as spectroscopy (assessment of prostatic metabolism), dynamic contrast-enhanced MRI (assessment of angiogenesis) and diffusion-weighted imaging (assessment of cellular density).  T2-weighted MRI is an important tool for local staging of prostate cancer in patients clinically staged as cT1 or cT2, because of its high specificity for macroscopic capsular extension or seminal vesicle invasion. Compared to CT-imaging, MRI depicts the internal prostatic anatomy, prostatic margins and the extent of prostatic tumors much more clearly. This benefit can be exploited to improve the accuracy of target delineations in radiotherapy planning.},
  author       = {Villeirs, Geert and De Visschere, Pieter and FONTEYNE, VALERIE and Lumen, Nicolaas and De Meerleer, Gert},
  issn         = {0001-5512},
  journal      = {ACTA CLINICA BELGICA},
  language     = {eng},
  number       = {6},
  pages        = {371--376},
  title        = {Magnetic resonance imaging in diagnosis, staging and radiotherapy planning for prostate cancer},
  volume       = {65},
  year         = {2010},
}

Web of Science
Times cited: